Tempo Scan Pacific Tbk PT
IDX:TSPC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
ID |
|
F
|
Fosun Tourism Group
HKEX:1992
|
CN |
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
F
|
Fujian South Highway Machinery Co Ltd
SSE:603280
|
CN |
|
JW Pharmaceutical Corp
KRX:001060
|
KR |
|
Ingredion Inc
NYSE:INGR
|
US |
|
Nabtesco Corp
TSE:6268
|
JP |
|
D
|
DT Cloud Star Acquisition Corp
NASDAQ:DTSQ
|
US |
|
R
|
Roquefort Therapeutics PLC
LSE:ROQ
|
UK |
|
Maisons du Monde SA
PAR:MDM
|
FR |
|
Antares Vision SpA
MIL:AV
|
IT |
|
N
|
NeoVolta Inc
NASDAQ:NEOV
|
US |
|
Loews Corp
NYSE:L
|
US |
|
Minim Inc
NASDAQ:MINM
|
US |
|
T
|
Trident Texofab Ltd
BSE:540726
|
IN |
|
Notable Labs Ltd
NASDAQ:NTBL
|
IL |
|
R
|
Rathdowney Resources Ltd
OTC:RATHF
|
CA |
|
A
|
Alset Inc
F:42A0
|
US |
|
S
|
Shakey's Pizza Asia Ventures Inc
XPHS:PIZZA
|
PH |
|
NU Skin Enterprises Inc
NYSE:NUS
|
US |
|
D
|
DS Sigma Holdings Bhd
KLSE:DSS
|
MY |
|
KT Corp
NYSE:KT
|
KR |
|
G
|
Golden Energy Offshore Services AS
OSE:GEOS
|
NO |
|
KT Corp
KRX:030200
|
KR |
Multiples-Based Value
The Multiples-Based Value of one TSPC stock under the Base Case scenario is hidden IDR. Compared to the current market price of 2 440 IDR, Tempo Scan Pacific Tbk PT is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
TSPC Competitors Multiples
Tempo Scan Pacific Tbk PT Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ID |
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
11T IDR | 0.8 | 7.3 | 4.1 | 4.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
837.7B USD | 12.9 | 40.6 | 27.4 | 29.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
583.9B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228B GBP | 5.2 | 29.9 | 16.6 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.3B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.3 | 21.4 | 13.3 | 17 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.9B USD | 2.5 | 20.3 | 7.8 | 10.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.4 | 8.7 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.1 | 7.2 | 8.9 |